BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026
Go back to BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026| (NASDAQ: BBIO) | Delayed: 66.58 -0.03 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.61 | 52 Week High | $ | |||
| Open | $67.01 | 52 Week Low | $ | |||
| Day High | $67.33 | P/E | N/A | |||
| Day Low | $65.78 | EPS | $ | |||
| Volume | 3,167,441 | |||||
